Clinical Research Directory
Browse clinical research sites, groups, and studies.
Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients
Sponsor: Dokuz Eylul University
Summary
Studies in the literature are limited both throughout Turkey and in general. For this reason, as a result of the study that we will create, it will provide us with information for bladder protective treatments in patients who do not respond to BCG therapy in bladder cancer patients.
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2024-04-09
Completion Date
2026-04-09
Last Updated
2024-04-19
Healthy Volunteers
No
Interventions
Intravesical Solution
Alkalinization of urine 1 day before the procedure Emptying the bladder with a catheter before the procedure mixing 1000 mg gemcitabine in 50 ml saline 90 minutes after administration 37.5 mg docetaxel mixed 120 minutes after administration in 50 ml saline maintanence if there is a 6 week induction response
Locations (1)
Dokuz Eylul University Faculty of Medicine Department of Urology
Izmir, Other (Non U.s.), Turkey (Türkiye)